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CHAPTER TWO
Effect of a Hyperthermic Treatment on the
Pluripotent Hematopoietic Stem Cell in
Normal and Anemic Mice








Up to now, the hyperthermic sensitivity of pluripotent hematopoietic stem cells is
unknown, and the few existing data from reports in the literature are conflicting. There
are two main drawbacks in the set-up of those studies: 1) only CFU-S-day 8 results
were presented, whereas it is questionable if this assay gives a true reflection of the
pluripotent stem cell, and 2) no attention has been paid to heat effects on the seeding
efficiency, i.e. the amount of stem cells which will lodge in the spleen. The present
study focused on the procedural differences and compared the results of a hyperther-
mic treatment (60 minutes at 42EC) on the stem cells, assayed with the CFU-S-day 8
and the CFU-S-day 12 method, using the following three stem cell suspensions, all
differing in their proliferative activity: bone marrow from normal mice and bone marrow
and spleen cells from anemic mice. Furthermore, we investigated the seeding effi-
ciency before and after the heat treatment. Resting stem cells, assayed with the CFU-
S-day 12 method, turned out to be  resistant to hyperthermia as compared with the
active cycling stem cells, while with the CFU-S-day 8 assay the stem cells showed the
same thermosensitivity in the two bone marrow suspensions. The active cycling stem
cells do not significantly differ in thermosensitivity, in CFU-S-day 8 and day 12 assays,
although there is a difference between bone marrow and spleen. Hyperthermia
appears to influence the seeding efficiency for spleen CFU-S; an increase of 1.73 was
observed. The difference in heat sensitivity between the resting and the active cycling
stem cells, assayed with both in vivo methods, however, cannot be explained by a
change in the seeding efficiency only. Comparing the amount of cycling cells in the
three stem cell suspensions and their thermosensitivity leads to the conclusion that the
differences in heat sensitivity might be fully explained by the cycling status of the stem
cell.
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INTRODUCTION
Blood cell formation depends on the proliferation and differentiation of hemato-
poietic pluripotent stem cells. Because of the dependence of all the different hemato-
poietic cell lineages on this stem cell the hyperthermic effect on the pluripotent
hematopoietic stem cell is of great interest. There have been some studies on the
effect of heat on the hematopoietic stem cell compartment. The main purpose of those
studies was to investigate the possibility of purging the bone marrow from leukemic
cells with the aid of hyperthermia in order to make the marrow feasible for autologous
transplantation (Symonds et al., 1981; Robins et al., 1983; Flentje t al., 1984;
Moriyama et al., 1986; Okamoto et al., 1988; Robins et al., 1988;). Furthermore this
type of studies is important because the hematopoietic stem cell compartment may be
the limiting normal tissue during cancer treatment with combined modalities including
hyperthermia. Up to now, the results of the different heat treatments are not unanimous
in elucidating the thermosensitivity of the resting and active cycling hematopoietic stem
cells. 
Pluripotent hematopoietic stem cells are in general assayed by the CFU-S
(Colony Forming Unit in the Spleen) method (Till and McCulloch, 1961). To translate
the CFU-S values into pluripotent hematopoietic stem cell numbers the fraction of stem
cells lodging in the spleen must be known: the seeding efficiency expressed as the
f-factor. One has to be aware of a possible change of the seeding efficiency due to the
hyperthermic treatment, and as a consequence of its implications on the outcome of
the experiments. In the hyperthermic studies on bone marrow cells performed up to
now, little or no attention has been paid to the seeding efficiency. 
Furthermore, in all reports published, the effect of heat was studied with the
CFU-S-day 8 (CFU-S-8) assay. It is questionable however, if the colony appearing at
day 8 after transplantation is a real reflection of the pluripotent hematopoietic stem cell
(Magli et al., 1982; Harris et al., 1984; Priestly and Wolf, 1985). Instead of the CFU-S-
8 assay, which probably detects committed stem cells, it is claimed in those studies
that the CFU-S-day 12 (CFU-S-12) assay is a better method to measure the pluripotent
hematopoietic stem cell.
The aim of the present study was to address these issues in the light of
clarifying the effect of heat on resting and active cycling pluripotent hematopoietic
stem cells. We determined the seeding efficiency before and after the heat treatment




Mice. Male and female C57Bl mice (9-12 wk) were used throughout the study
and were obtained from the Central Animal Facility of the Medical Faculty, State
University Groningen. The mice were bred under SPF conditions and kept in clean
conventional rooms during the experiments.
Cells. Normal bone marrow cells were isolated by flushing the two femora of
untreated mice with alpha-medium (GIBCO Laboratories, Grand Islands, NY, USA)
buffered with 20 mM morpholinopropane sulfonic acid (Janssen Chimica, Beerse,
Belgium). The medium was supplemented with 10% fetal calf serum (Hy Clone, Logan,
UT, USA).
Bone marrow cells from anemic mice were isolated as described for the normal
untreated mice. The mice were made anemic by bleeding them on three consecutive
days by orbital punction (0.5 ml per day). Four days after starting the bleeding
procedure, cells were harvested.
The isolation of spleen cells was the same as previously described (Nijhof et al.,
1982). Briefly, mice were treated with thiamphenicol for 5 days via a subcutaneously
implanted dialysis bag. The mice were bled on 2 consecutive days as described
above. Three days after removal of the drug the spleen was squeezed through a fine
mesh metal screen into 3 ml of alpha-medium. As a result of the thiamphenicol
treatment, hematopoiesis is highly stimulated in the spleens of the mice.
All three cell suspensions were dispersed through a 21 Gauge needle. Cell
counts were performed on a Coulter Counter - Model ZF (Coulter Electronics Inc.,
Hialeah, FL, USA).
Heat Treatment. The isolated cells were heated at a cell concentration of 2-3 x
10 /ml in the same medium as listed to prepare the cell suspensions. The hyperthermic7
treatment was performed in a precision water bath, maintained at the desired tempera-
ture within 0.1EC. After the heat treatment, cells were put on ice and diluted to the
appropriate cell concentration for the CFU-S assay.
Spleen Colony Assay. To determine the amount of pluripotent hematopoietic
stem cells the spleen colony assay was used (Till and McCulloch, 1961). The recipient
mice were irradiated with a dose of 9 Gy by an X-ray machine (Philips MG 300, 200
kV, 15 mA, 0.5 mm Al, 0.5 mm Cu, 0.5 Gy.min). For each series of experiments the-1
following procedure was used. Control and heated cell suspensions were intrave-
nously (orbital) injected in a group of 20 mice, 24 hours after irradiation. After eight
days, 10 of the mice were killed by cervical dislocation and the spleens were fixed in
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Bouins solution. The other 10 mice were sacrificed after 12 days and their spleens,
were treated as the day 8 group. The number of macroscopic colonies on the surface
of each spleen was counted. The endogenous spleen colonies turned out to be zero
as a result of the relatively high X-ray dose used.
Seeding Efficiency Assay. The seeding efficiency (f-factor) was measured with
the double-transplant technique (Siminovitch, 1963). All recipients received a 9 Gy X-
ray dose. As for the spleen colony assay, it was decided to irradiate the recipients 24
hours before the transplantation. This procedure was chosen, because of the fact that
the f-factor should be determined from the number of CFU-S recoverable from fully
shrunken spleens (Lord and Hendry, 1973). After an irradiation dose of >8.5 Gy the
shrinkage of the spleen is completed within 24 hours (Testa et al., 1972; Monette and
DeMello, 1979). The first transplant consisted of 500-1000 times the number of cells
injected into a parallel series of mice, according to the method mentioned in the
previous section. The amount of CFU-S, which will lodge in the spleen of the recipient,






Assay. The factors 25
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So, after a time interval of 2-3 hours the spleen was removed and dispersed to
form a single cell suspension. The second transplant consisted of a known number of
this spleen cell suspension (between 5-10% of the total spleen mass per mouse) into a
group of irradiated recipients in order to determine the CFU-S content. It should be
noted that in the double transplant technique it is assumed that the f-factor in both
transplants is the same (Hendry, 1971). Figure 2.1 shows the method for the determi-




It was decided to give hyperthermic treatments at 42EC for the sake of compari-
son, because this temperature was used in earlier reports revealing thermosensitivity
differences between resting and regenerating bone marrow cells (Flentje et al., 1984;
Baeza et al., 1987). Since all the studies reported up to now used the CFU-S-8 values
to determine the heat sensitivity of the hematopoietic stem cell, we also employed this
assay and compared the results with those obtained from the CFU-S-12 experiments.
Figure 2.2 shows the results of the hyperthermic treatment on stem cells when the
CFU-S-8 and CFU-S-12 are compared. In normal bone marrow we found a surviving
fraction of 49 ± 4% for the CFU-S-8, comparable to the bone marrow from anemic mice
showing a survival of 52 ± 6%. The surviving fraction of the spleen cells from anemic
mice turned out to be 24 ± 1%. The incubation of cells for 60 minutes at 37EC has no
effect on cell survival (data not shown). As can be seen, the heat effect on the CFU-S-
12 is not significantly different from the CFU-S-8 as far as the anaemic bone marrow
and spleen cells are concerned: 62 ± 1% and 28 ± 3%, respectively. For normal bone
marrow, however, there is a significant difference detectable between the two ways of
assaying heat sensitivity, i.e. 98 ± 4% versus 49 ± 4% when CFU-S-12 and CFU-S-8 is
compared.
Figure 2.2. The effect of a hy-
perthermic treatment (60 min-
utes at 42EC). on CFU-S-8 and
CFU-S-12. Hyperthermia was per-
formed as described in Materials
and Methods (n=3). The results are
related to the surviving fraction of
the untreated cells (=100%). Bars=
SD. Statistical analysis: student t-
test, p<0.05.
A change in seeding efficiency (f-factor) of the transplanted CFU-S, due to the
heat treatment, would lead to a misinterpretation of the obtained data. To examine this
change, if any, we determined the f-factor before and after the heat treatment. As can
be seen in Figure 2.3, there is no significant change in f-factor detectable in normal
and anemic bone marrow CFU-S, whereas the spleen CFU-S demonstrated an
increase of 1.73 compared with the untreated spleen CFU-S. These data appear to be
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the same for the CFU-S-8 and CFU-S-12 assays. The main reason for determining the
seeding efficiency is the need to estimate the amount of pluripotent hematopoietic
stem cells in the used cell suspensions. Adjusting the CFU-S-12 values in Figure 2.2
for the f-factor results in the following surviving fraction of the pluripotent hematopoi-
etic stem cell in normal bone marrow, anemic bone marrow and anemic spleen: 1-
00±13%, 59±8% and 15±3%, respectively. It is clear from these data that besides a 
Figure 2.3. Change in seeding efficiency after a hyperthermic treatment (60 minutes at
42EC). The change in seeding efficiency is expressed as a factor, related to the seeding
efficiency of the untreated cells. Bars= SD. Statistical analysis: see Figure 2.2.
difference in heat sensitivity between pluripotent hematopoietic stem cells under
normal and anemic condition, there is also a significant difference in thermal effect in
the two anemic situations. This difference might be caused by a difference of prolifera-
tive activity of the cells in suspension.
In a previous study we determined the percentage of CFU-S present in the S-phase in
different cell suspensions using a 'thymidine-suicide' technique (Nijhof and Wierenga,
1985). In normal bone marrow only 8 ± 0.1% of the CFU-S is killed by the H-thymidine3
incorporation. This value increases to 34 ± 8% when the mice are made anaemic. In
the ex-TAP spleens the thymidine kill even reaches up to 65 ± 4%. Figure 2.4 shows
the relation between thymidine kill and the surviving fraction after the heat treatment. It
is obvious that there is a strong correlation (r=0.9995) between the decrease in
survival and the increase in percentage S-phase cells in the stem cell suspensions.
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Figure 2.4. The relationship between heat sensitivity (surviving fraction) and prolifera-
tive state (thymidine kill) of the pluripotent hematopoietic stem cells from bone marrow
of normal mice (9 ), bone marrow from anaemic mice ( ) and from spleens of
anaemic mice ( ).
DISCUSSION
Whereas S-phase cells are more radioresistant than cells in the other phases of
the cell cycle, the S-phase and the M-phase appear to be the most heat-sensitive
stages of the cell cycle (Dewey et al., 1977; Hahn, 1982). If the cycle state is a factor
in explaining the difference in thermosensitivity one would expect differences between
resting and active cycling hematopoietic stem cells. In reports in which the hematopoi-
etic stem cell compartment was used as a model for studying normal tissue damage in
hyperthermia, results are conflicting. It was observed that active cycling hematopoietic
stem cells in the bone marrow are more sensitive to a heat treatment at 42EC th n the
resting stem cell (Flentje et al., 1984) while this difference was not observed by others
(Baeza et al., 1987). At 43EC nodifference in heat sensitivity was found between 
proliferating and resting bone marrow stem cells (Wang et al., 1985). In contrast to the
situation in bone marrow, Baeza t l. (1987) did find a difference between active
cycling and resting stem cells in the spleen. 
There is substantial evidence at the moment that, instead of the CFU-S-8 cells,
CFU-S-12 cells are derived from the pluripotent stem cell, at least in normal bone
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marrow. Magli et al. (1982) observed that 7-9 days after the transplantation recogniz-
able cells of one hematopoietic lineage were present in the colonies, whereas at day
14 most of the spleen colonies contained cells of more than one hematopoietic cell
line. Harris et al. (1984) reported antigenic differences between CFU-S-8 and CFU-S-
day 14 cells. Priestly and Wolf (1985) used a surgical technique which enabled them
to follow the colony development of the CFU-S from the moment of transplantation until
day 14. They found that the CFU-S-12 is a late-appearing colony, not predominantly
present at day 8. Data from Molineux et al. (1986) show no persistence of colonies
from day 7-9 to day 12-14. In their paper it is also shown that the CFU-S-12 colonies
are novel colonies appearing between day 8 and 11 after injection. All these studies
suggest that only when colonies are scored between days 11-14, the CFU-S technique
provides a measure of the pluripotent hematopoietic stem cell and spleen colonies
between day 7-9 are assumed to be representative of committed stem cells. Our
results (Figure 2.2) indicate a difference in heat sensitivity between CFU-S-8 and
CFU-S-12 in normal bone marrow. This can be explained by the fact that in normal
bone marrow the CFU-S-8 is already active proliferating (Shibagaki et al., 1986), in
contrast to the CFU-S-12. In the anemic bone marrow we did not find a significant
difference in heat sensitivity between CFU-S- day 8 and CFU-S-12. Because of the
hematopoietic pressure in the anemic situation, the resting CFU-S-12 will, like the
CFU-S-8, become active proliferating and as a consequence more heat-sensitive.
If it is true, as stated by Magli et al. (1982) and Harris et al. (1984), that in
normal bone marrow the CFU-S-8 assay appears to detect the BFU-E or CFU-GM, it is
interesting to compare our results with those of others, performed on the committed
hematopoietic stem cell compartment (Bromer et al., 1982; Elkon et al., 1981; Mivechi
and Li, 1986; Van Zant e  al., 1983)). In those studies the surviving fraction of the
committed stem cells decreases to values comparable to our CFU-S-8 results. In a
recent paper by Goris et al. (1989) it is shown that in normal bone marrow the commit-
ted stem cells are active proliferating, which is in agreement with the detected increase
in heat sensitivity of the CFU-S-8 in normal bone marrow. So, our in vivo results
correlates very well with results from the regular in vitro culture assay for committed
stem cells.
Up to now little or no attention has been paid to the seeding efficiency of the
injected cells. Because the heat treatment may alter the plasma membrane (Konings,
1988) this might influence the lodging ability of the cells in the spleen. This possibility
was only investigated for leukemic cells (Flentje et al., 1984) and appeared not to
change during hyperthermic treatment. We too found no significant alterations in the
seeding efficiency of bone marrow stem cells. The spleen CFU-S, however, behaved
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quite differently and showed an increase in the f-factor. At the moment the divergent
behavior of the spleen CFU-S is unclear. Knowledge of the f-factor before and after the
heat treatment is essential to translate the CFU-S-12 numbers into pluripotent hemato-
poietic stem cell numbers. The aggregated results lead to the following conclusions:
using CFU-S-12 data there is a difference in heat sensitivity between resting and
cycling pluripotent hematopoietic stem cells, and there is a strong correlation between
the proliferating status and thermal sensitivity.
Several mechanisms by which hyperthermia might cause cell death are pro-
posed (Konings, 1987). The proliferative activity as well as the organ source are
believed to be important factors in the heat sensitivity of the cells (Baeza et al., 1987).
Our results imply, that the difference in heat sensitivity between hematopoietic stem
cells mainly depends on the amount of proliferative stem cells. Because of the low
incidence of the stem cells in the bone marrow and spleen, the accessory cells may
also play an important role (Symonds et al., 1981). To elucidate a possible role of
these accessory cells, as well as the origin of the organ source, we are performing
hyperthermic experiments on purified pluripotent and progenitor hematopoietic stem
cells at the moment.
